Literature DB >> 5461122

Maintenance of pregnancy in protein-deficient rats with dietary supplements of methionine.

W G Kinzey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5461122     DOI： 10.3181/00379727-133-34494

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  10 in total

1.  Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition.

Authors:  Atiye Seda Yar Saglam; Handan Kayhan; Ebru Alp; Hacer Ilke Onen
Journal:  Mol Biol Rep       Date:  2021-01-03       Impact factor: 2.316

2.  SOX2-OT induced by PAI-1 promotes triple-negative breast cancer cells metastasis by sponging miR-942-5p and activating PI3K/Akt signaling.

Authors:  Wenwen Zhang; Shuofei Yang; Datian Chen; Daolu Yuwen; Juan Zhang; Xiaowei Wei; Xin Han; Xiaoxiang Guan
Journal:  Cell Mol Life Sci       Date:  2022-01-07       Impact factor: 9.261

Review 3.  Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.

Authors:  Giampaolo Bianchini; Carmine De Angelis; Luca Licata; Luca Gianni
Journal:  Nat Rev Clin Oncol       Date:  2021-11-09       Impact factor: 66.675

4.  Genomic features of rapid versus late relapse in triple negative breast cancer.

Authors:  Yiqing Zhang; Sarah Asad; Zachary Weber; David Tallman; William Nock; Meghan Wyse; Jerome F Bey; Kristin L Dean; Elizabeth J Adams; Sinclair Stockard; Jasneet Singh; Eric P Winer; Nancy U Lin; Yi-Zhou Jiang; Ding Ma; Peng Wang; Leming Shi; Wei Huang; Zhi-Ming Shao; Mathew Cherian; Maryam B Lustberg; Bhuvaneswari Ramaswamy; Sagar Sardesai; Jeffrey VanDeusen; Nicole Williams; Robert Wesolowski; Samilia Obeng-Gyasi; Gina M Sizemore; Steven T Sizemore; Claire Verschraegen; Daniel G Stover
Journal:  BMC Cancer       Date:  2021-05-18       Impact factor: 4.430

5.  Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model.

Authors:  Sofia M Saraiva; Carlha Gutiérrez-Lovera; Jeannette Martínez-Val; Sainza Lores; Belén L Bouzo; Sandra Díez-Villares; Sandra Alijas; Alba Pensado-López; Abi Judit Vázquez-Ríos; Laura Sánchez; María de la Fuente
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

6.  Carnitine palmitoyl transferase 1A is a novel diagnostic and predictive biomarker for breast cancer.

Authors:  Zheqiong Tan; Yaru Zou; Man Zhu; Zhenzhao Luo; Tangwei Wu; Chao Zheng; Aqing Xie; Hui Wang; Shiqiang Fang; Shuiyi Liu; Yong Li; Zhongxin Lu
Journal:  BMC Cancer       Date:  2021-04-15       Impact factor: 4.430

7.  Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer.

Authors:  Xiuzhi Zhu; Li Chen; Binhao Huang; Xiaoguang Li; Liu Yang; Xin Hu; Yizhou Jiang; Zhimin Shao; Zhonghua Wang
Journal:  J Exp Clin Cancer Res       Date:  2021-04-08

8.  Integrative analysis of genomic amplification-dependent expression and loss-of-function screen identifies ASAP1 as a driver gene in triple-negative breast cancer progression.

Authors:  Jichao He; Ronan P McLaughlin; Lambert van der Beek; Sander Canisius; Lodewyk Wessels; Marcel Smid; John W M Martens; John A Foekens; Yinghui Zhang; Bob van de Water
Journal:  Oncogene       Date:  2020-03-31       Impact factor: 9.867

9.  Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC.

Authors:  Renbo Tan; Haoyang Li; Zhenyu Huang; Yi Zhou; Mingxin Tao; Xin Gao; Ying Xu
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

10.  Mitochondrial copper depletion suppresses triple-negative breast cancer in mice.

Authors:  Liyang Cui; Arvin M Gouw; Edward L LaGory; Shenghao Guo; Nabeel Attarwala; Yao Tang; Ji Qi; Yun-Sheng Chen; Zhou Gao; Kerriann M Casey; Arkadiy A Bazhin; Min Chen; Leeann Hu; Jinghang Xie; Mingxi Fang; Cissy Zhang; Qihua Zhu; Zhiyuan Wang; Amato J Giaccia; Sanjiv Sam Gambhir; Weiping Zhu; Dean W Felsher; Mark D Pegram; Elena A Goun; Anne Le; Jianghong Rao
Journal:  Nat Biotechnol       Date:  2020-10-19       Impact factor: 54.908
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.